Clinical trials recruiting for Gastroesophageal Junction Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 5-Fluorouracil | 1 |
| AZD0901 | 1 |
| BL-M07D1 | 1 |
| DR-0202 | 1 |
| Gemcitabine | 1 |
| IKS014 | 1 |
| Irinotecan | 1 |
| Leucovorin | 1 |
| MCLA-158 | 1 |
| MCLA-158 + FOLFIRI | 1 |
| MCLA-158 + FOLFOX | 1 |
| MCLA-158 + Pembrolizumab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 5 |
| California | 4 |
| Florida | 3 |
| Massachusetts | 3 |
| New York | 3 |
| Tennessee | 3 |
| Virginia | 3 |
| Colorado | 2 |
| Georgia | 2 |
| Michigan | 2 |
| Oklahoma | 2 |
| Alabama | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- IKS014 in Advanced Solid Tumors That Express HER2
- Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Related conditions
Trials recruiting for Gastroesophageal Junction Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Gastroesophageal Junction Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.